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Abstract
Breaking the balance between proliferation and differentiation in animal cells can lead to cancer, but the mechanisms
maintaining this balance remain largely undefined. The calcium activated chloride channel A1 (CLCA1) is a member of the
calcium sensitive chloride conductance family of proteins and is expressed mainly in the colon, small intestine and
appendix. We show that CLCA1 plays a functional role in differentiation and proliferation of Caco-2 cells and of intestinal
tissue. Caco-2 cells spontaneously differentiate either in confluent culture or when treated with butyrate, a molecule present
naturally in the diet. Here, we compared CLCA1 expressional levels between patients with and without colorectal cancer
(CRC) and determined the functional role of CLCA1 in differentiation and proliferation of Caco-2 cells. We showed that: 1)
CLCA1 and CLCA4 expression were down-regulated significantly in CRC patients; 2) CLCA1 expression was up-regulated in
Caco-2 cells induced to differentiate by confluent culture or by treatment with sodium butyrate (NaBT); 3) Knockdown of
CLCA1 with siRNA significantly inhibited cell differentiation and promoted cell proliferation in Caco-2 confluent cultures,
and 4) In Caco-2 3D culture, suppression of CLCA1 significantly increased cell proliferation and compromised NaBT-induced
inhibition of proliferation. In conclusion, CLCA1 may contribute to promoting spontaneous differentiation and reducing
proliferation of Caco-2 cells and may be a target of NaBT-induced inhibition of proliferation and therefore a potential
diagnostic marker for CRC prognosis.
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Introduction
In mammalian intestine the enterocytes are renewed continually
every 4–8 days. This occurs through a coordinated series of events
involving proliferation, differentiation, and migration from the
intestinal crypts upwards toward the lumen [1]. Disruption of the
balance between cell division and differentiation can lead to
disease states such as cancer [2]. Alterations of the tightly
regulated balance between the highly proliferative/less differenti-
ated enterocytes and the non-proliferative/highly differentiated
state may lead to hyperplasia, benign (polyps) or malignant tumors
[3]. The Wnt signaling pathway is the primary mechanism
controlling proliferation of enterocytes in the intestinal crypts [4].
Ion channels contribute to tumors by regulating the basic
cellular processes of proliferation, differentiation, and apoptosis
[5]. For example, KCNK9 (potassium channel subfamily K
member 9) is overexpressed and contributes to tumorigenesis by
promoting cancer cell survival in breast cancer [6]. GIRK1 (G-
protein inwardly rectifying potassium channel 1) expression
increased in 50/72 non-small-cell lung cancer patients and the
presence of this mRNA was associated with significantly reduced
five-year survival rates [7]. In addition, the TRPM8 channel
protein (Transient receptor potential cation channel subfamily M
member 8) a prostate-specific marker was up-regulated in tumor
tissue [8]. Studies describing the occurrence of individual ion
channels in tumor cells and their functional consequences on
growth, migration, or invasion are increasing [9].
In the colon, chloride channels (CLCs) form a large functional
family with structurally diverse members that play an important
role in the regulation of epithelial fluid and electrolyte transport
[10]. Activation of the chloride current through specialized
volume-regulated anion channels (VRACs) in response to cell
swelling (ICl, swell) is one of the major mechanisms by which cells
restore their volume following hypo-osmotic stress (RVD) [11].
This is important since there is a direct link between apoptotic
resistance conferred by the antiapoptotic Bcl-2 protein and the
strengthening of RVD capability due to up-regulation of ICl, swell
[12]. In addition, the Chloride channel 3 (CLC3) protein is among
the prostate-specific VRACs and is up-regulated in androgen-
independent prostate cancer cells [13]. Calcium-activated chloride
channels (CLCAs) also are expressed in bovine [14], mouse [15]
and human [16] enterocytes and there is an inverse correlation
between the levels of chloride channel (CLCA1 and CLCA2)
expression and tumorigenicity, indicating that they act as
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suppressors of breast and colorectal cancer [17,18,19]. However,
the detailed biological function of CLCAs remains to be
determined. Therefore, we investigated whether CLCA1 contrib-
utes to tumorigenesis by regulating the balance between prolifer-
ation and differentiation in enterocytes.
The human intestinal cancer cell line Caco-2 is a well-
established model system to study cellular differentiation of human
enterocytes since it differentiates spontaneously into polarized cells
with morphological and biochemical features of small intestinal
enterocytes [20]. Additionally, Caco-2 cells also differentiate when
exposed to the physiologically relevant short-chain fatty acid,
butyrate [19]. Short chain fatty acids (SCFA), principally butyrate,
propionate and acetate, are produced in the gut through the
fermentation of dietary fiber by the colonic microbiota [21].
Butyrate in particular is the preferred energy source for the cells of
the colonic mucosa and exerts various biological effects on
cultured mammalian cells, including inhibition of cell prolifera-
tion, apoptosis and induction of differentiation [22,23]. Because of
this, its therapeutic potential in colon cancer has been proposed
[23]. Caco-2 cells, when grown as a confluent monolayer or
exposed to sodium butyrate (NaBT) treatment, differentiate to
mimic phenotypically and functionally mature colonic epithelium
and are a useful model for investigating the molecular mechanisms
of differentiation in CRC. Here, we demonstrate that CLCA1
(Calcium-activated chloride channel family member 1) plays a
functional role in regulating the differentiation and proliferation of
Caco-2 cells.
Results
Down-regulation of CLCA1 Expression in Colorectal
cancer (CRC) Patients
Firstly, we investigated the expression level in humans of
chloride channels in normal and tumour tissues using the
microarray database of NCBI (http://www.ncbi.nlm.nih.gov/
geo/). The expression levels of CLCN2, CLCN3, CLCA1,
CLCA4 and CFTR in early CRC patient were significantly
reduced 31%, 59%, 74%, 41% and 58% respectively compared to
normal colonic mucosa (Fig. 1A). To further confirm the down-
regulation of CLCA1 in CRC patients, we used immunofluores-
cent staining to detect CLCA1 expression in both CRC and
normal intestinal tissues and found the expression of CLCA1
reduced significantly in CRC intestinal tissues (Fig. 1B). One of the
features in tumorigenesis is the high proliferation/low differenti-
ation rate of cells. Perhaps CLCA1 contributes to tumorigenesis by
regulating the balance between proliferation and differentiation in
enterocytes.
Up-regulation of CLCA1 Induced by Sodium Butyrate in
Caco-2 Cells
A pro-differentiating effect of sodium butyrate (NaBT) has been
studied extensively in various malignant cell lines [24,25]. We
analyzed Ca2+–dependent chloride channel expression patterns in
Caco-2 cells using quantitative RT-PCR assay (qPCR). We found
that expression levels of CLCA1 and CLCA3 were upregulated
35-fold and over 100-fold respectively after 2 mM NaBT
treatment for 24 hours (Fig. 2A). Western blots additionally
showed that the CLCA1 protein increase was time-dependent.
When Caco-2 cells were treated with NaBT for 24 hours, CLCA1
expression was upregulated significantly compared to the no
treatment group (Fig. 2B). However, there was little or no
expression of CLCA1 following shorter exposure (8 and 12 hours
treatments, Fig. 2B). Expression of CLCA1 in monolayers not
treated with NaBT also displayed a significant increase at 24 hours
(compared to 8 and 12 hours cultures) due to the spontaneous
differentiation of Caco-2 cells in confluent cultures (Fig. 2B).
NaBT also elevated the expression of intestinal alkaline phospha-
tase (ALPI) and b-catenin in Caco-2 cells (Fig. 2C). Both are
markers of enterocyte differentiation and are upregulated in
differentiated cells. Our data suggest that CLCA1 may mediate
the cell differentiation induced by confluent culture and by NaBT
in Caco-2 cells.
CLCA1 is Upregulated at an Early Stage during
Spontaneous Differentiation of Caco-2 Cells in Confluent
Culture
Culture to confluence induces the spontaneous differentiation of
Caco-2 cells [19,24,25,26]. Using this model, we asked whether
CLCA1 contributed to the differentiation of Caco-2 cells. Firstly,
we detected the expression of CLCA1 and the two differentiation
markers ALPI and sucrase-isomaltase (SI) in confluent culture. We
found that expression of CLCA1 (including the two different cell-
surface-associated subunits 38 KD and 90 KD [16]) was detected
at very low levels at the beginning of the culture. However, as
cultures became confluent, CLCA1 expression started to increase
in a time dependent manner. This increase in expression was
evident within 1 day (Fig. 3A, 3B). Expression of ALPI and SI also
showed a significant time dependent up-regulation, but this did
not occur until day 4, later than for CLCA1 expression (Fig. 3C,
3D). In addition, we detected also the expression of b-catenin at
different days of Caco-2 cell confluent culture. We found that the
b-catenin increased slightly in Caco-2 confluent monolayer
(Fig. 3E). Subcellular fractionation studies showed that the
increase of b-catenin was attributable to an increase in the
membrane fraction of b-catenin, whereas cytosolic levels remained
unchanged (Fig. 4B) [27]. These data suggest that the expression of
CLCA1 may contribute to the spontaneous differentiation of
Caco-2 cells.
CLCA1 is Required for Spontaneous Differentiation of
Caco-2 Cells
To determine the functional role of CLCA1 in Caco-2 cell
differentiation, we used a stealth short-interfering RNA (siR-
NAclca1) to knock-down the expression of CLCA1 in Caco-2 cells.
After 72 hr transfection, cells were tested for expression of
CLCA1, ALPI and b-catenin by western blot (Fig. 4A). Our data
showed that CLCA1 expression was downregulated in a dose-
dependent manner in response to increasing transfection concen-
trations of siRNAclca1. To avoid off-target effects by higher
concentration of siRNA, we chose 100 nM siRNAclca1 as an
optimal concentration for subsequent experiments.
ALPI and b-catenin expression were reduced significantly upon
CLCA1 knockdown. Moreover, confocal imaging showed a
reduced cell membrane staining of b-catenin in siRNAclca1
knockdown cells (Fig. 4B). To further confirm the pro-differenti-
ation role of CLCA1 in Caco-2 cells, we detected ALP activity
using a cell differentiation detection kit in Caco-2 cells. Our data
demonstrated that ALP activity was inhibited significantly in
CLCA1 knockdown cells (Fig. 4C). These results indicated that the
CLCA1 plays a key role in regulation of spontaneous differenti-
ation of Caco-2 cells.
CLCA1 Plays an Anti-proliferative Role in Caco-2 Cells
The antiproliferative effect of NaBT has been studied
extensively in various malignant cell lines [25]. To verify whether
CLCA1 presented an anti-proliferative effect on Caco-2 cells, we
cultured cells in 3D Matrigel for 5 days to form colonies. We found
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that the mean colony size in Caco-2 CLCA1KD cells increased
significantly compared with wild type cells (p,0.01, n= 50 each).
When cells were treated with 2 mM NaBT, the colony size was
inhibited significantly in Caco-2 cells, but in CLCA1KD cells with
treatment of NaBT the colony size was not reduced significantly
(p.0.05, n= 50 each) (Fig. 5A). These results indicate that the
antiproliferative effect of NaBT could be mediated by CLCA1. To
further confirm the effect of CLCA1 on proliferation, we assessed
this via ethynyldeoxyuridine (EdU) incorporation in Caco-2 cells.
We found that proliferation of Caco-2 cells was reduced in 3 day
confluent cultures. However, proliferation of Caco-2 cells was
promoted significantly in siRNAclca1 treated cells when compared
to a siRNA negative control cells (p,0.01, n= 100 each) (Fig. 5B).
Together with the 3D culture, these results show that the
expression of CLCA1 contributes to the regulation of proliferation
in Caco-2 cells.
Discussion
The proliferation to differentiation transition (PDT) is a critical
step in the continual renewal of a normal intestinal epithelium [1]
and colon epithelial cells are amongst the best-studied models of
tumorigenesis since their constant renewal requires close regula-
tion of the PDT [3,28]. Many genetic lesions, including mutation
of APC and p53, produce neoplastic transformation of the colon
enterocyte. In addition, during organogenesis, stem cells execute
the silencing of proliferation genes and the activation of
differentiation genes in a step-wise temporal manner. Important
insights about the molecules that may serve as targets for therapy
would be gained from a full understanding of the molecular
mechanisms of these processes. Here, we found that the calcium
activated chloride channel CLCA1 plays a crucial role in
regulation and maintenance of PDT in colon enterocyte, since
loss of CLCA1 led to reversion of cells to a low-differentiated
status.
CLCA1 Regulates the PDT in Intestinal Epithelial Cells
The PDT of single progenitor cell is tightly regulated by
morphogens, growth factors and hormones [29] and molecular
alterations to specific components of the signaling pathways used
by these different classes of molecule are important during the
development of cancer [30]. Of these changes, upregulation of
CDK inhibitors (CKI) p21Cip1/WAF1 and p27Kip1 in many
terminally differentiating cells [31], Wnt/b-catenin signaling
inducing muscle cell differentiation [32], SOX9-dependent PKCa
repression favoring proliferation and inhibiting differentiation [33]
have been reported. Our previous study has demonstrated that
CLC-2, CLC-4 (chloride channel 2 and 4) and CFTR (cystic
fibrosis transmembrane regulator, a chloride channel) were
expressed at significantly higher level in freshly isolated human
corneal tissues than in cultured epithelial cells (primary culture or
cell line) [34]. As the number of cell-layers increases, the gene
expression level and protein staining intensity of CLCA2 (calcium-
activated chloride channel member 2) was increased significantly
[35]. This indicates that the CLCs (Chloride channels) may
contribute to the regulation of differentiation in the development
of epithelial tissues. In addition, the activity of Cl2 channels varies
with the cell cycle and loss of calcium-activated chloride channels
would afford a significant growth advantage to tumor cells
[14,15,35,36,37]. In CRC, CLCA1 and CLCA2 was downregu-
lated significantly in approximately 80% of patients [19]. The loss
of expression of both mCLCA1 and mCLCA2 during tumorigen-
esis suggested that strong activation of either might inhibit survival
of tumor cells [16]. CLCA2 is required for epithelial differenti-
ation, and its loss during tumor progression contributes to
metastasis [38]. Proliferating Caco-2 cells spontaneously initiate
the differentiation process when the cells have reached confluence.
This cellular differentiation program is initiated upon cell–cell
contact and the switch from proliferation to differentiation may be
triggered by specific biochemical events including E-cadherin
mediated cell–cell adhesion [20]. Chloride channels are mem-
brane protein and may play an important role in cell-cell
communication after cell-cell adhesion. Collectively, this implies
that the CLCAs might play a functional role in tumorigenesis
through controlling the proliferation and differentiation balance.
The CLCA1 precursor is about 900 amino acids long with one
proteolytic cleavage site following the amino-terminal signal
sequence. Eventually, two products of a 90-kDa and a 30–40-
kDa play functional roles [15,16,36,37]. CLCA1 is closely
correlated with transcription of c-myc, a proto-oncogene whose
product is intimately involved in the regulation of cell proliferation
and apoptosis [39]. In this study, we found using microarray that
the expression of CLC2, CLC3, CLCA1, CLCA4 and CFTR
were down-regulated significantly in early CRC patients and this
reduced expression of CLCA1 was confirmed by immunofluores-
cent staining of tissue from CRC patients (Fig. 1). In addition,
in vitro we showed that CLCA1 was involved in regulating the
differentiation and proliferation of Caco-2 cells. When CLCA1 in
Caco-2 cells was inhibited with siRNAclca1, both NaBT-induced
and spontaneous differentiation was reduced significantly (Fig. 4),
whereas proliferation increased significantly (Fig. 5). These data
suggest that activation of CLCA1 may be crucial in maintaining
the balance between differentiation and proliferation of enter-
ocytes.
In addition, the high tissue specificity of transcription of some
CLCs [40], initially suggested that detection of their mRNA in
specific tissues might be useful for early diagnosis, molecular
staging, and postoperative surveillance [19]. Importantly, our data
show that inappropriate transcription of chloride channels not
only included CLCA1, but also CLC2, CLC3, CLCA4 and
CFTR, indicating that defects of chloride transport or of chloride
current may play a key role in CRC. Activation of chloride current
through specialized volume-regulated anion channels (VRACs) is
one of the major mechanisms by which cells restore their volume
following hypo-osmotic stress (RVD) [11], whilst the transepithe-
lial transport of chloride also contributes to the transepithelial
potential difference (TEP) in intestine [41]. The TEP is an
inherent property of transporting epithelia and arises from
gradients of ions transported directionally across epithelial cell
layers. Across human intestine, there is a TEP of 22567 mV,
lumen negative. It will be interesting to test the novel notion that
the TEP may play regulatory roles in controlling PDT and
tumourgenesis of intestine.
Figure 1. Down-regulation of CLCA1 expression in CRC. A. Normalized raw expression values of chloride channel family members were
analyzed in human colonic mucosa and early CRC tissues from Gene Expression Omnibus (reference series is GSE4017). CLCA1, CLCA4, CLCN2, CLCN3
and CFTR were down-regulated significantly in early CRC patients. Values are mean6s.e.m, *p,0.01. B. Analysis of immunofluorescence
demonstrated that the expression of CLCA1 was reduced in CRC tissues in contrast to normal colonic mucosa. Bar = 50 mm.
doi:10.1371/journal.pone.0060861.g001
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b-catenin is Involved in CLCA1-driven Cell Proliferation
and Differentiation
The Wnt pathway is highly conserved throughout the animal
world [4]. b-catenin is a central molecule in the canonical Wnt
pathway that regulates intestinal epithelial differentiation
[4,42,43]. In addition, the b-catenin/TCF (T-cell factor) pathway
also regulates colonic epithelial cell proliferation [33]. In mouse
myoblast cells C2C12, Wnt signaling via b-catenin may act as a
molecular switch that regulates the transition from cell prolifer-
ation to myogenic differentiation [44]. In addition most instances
of CRCs arise from inactivating mutations in the adenomatous
polyposis coli (APC) gene, that controls b-catenin degradation
[28,45,46]. Collectively, this suggests that the b-catenin pathway
plays a key role in PDT. In Caco-2 confluent cultures, as they
differentiate, b-catenin showed a time dependent increase on the
cell membrane (Fig. 3) [27] and when CLCA1 was knocked down,
Figure 2. Sodium Butyrate (NaBT) up-regulated CLCA1 expression and promoted differentiation in Caco-2 cells. A. The mRNA
expression of CLCA1, A2, A3 and A4 were measured using quantitative RT-PCR. CLCA1 and CLCA3 were up-regulated respectively in Caco-2 cells after
treatment with 2 mM NaBT for 24 hours. Data are presented as mean 6 s.e.m from three independent experiments, *p,0.01. B. Caco-2 monolayer
was cultured for different time periods with/without 2 mM NaBT treatment. Expression of CLCA1 was detected by western blot. In 8 and 12 hours
confluent culture, neither control nor NaBT increased the expression of CLCA1. When Caco-2 monolayers were cultured for 24 hours, both control
and NaBT up-regulated CLCA1 expression, but NaBT enhanced CLCA1 expression much more than was seen in controls. C. NaBT elevated ALPI and b-
catenin expression (differentiation markers) in confluent cultures of Caco-2 cells. The histograms in B and C show the relative intensity of CLCA1
90 KD, ALPI and b-catenin expressed as a ratio with respect to the GAPDH control. All results were from three independent experiments.
doi:10.1371/journal.pone.0060861.g002
Figure 3. Expression of CLCA1, ALPI and sucrase-isomaltase was upregulated during spontaneous differentiation of Caco-2
monolayer. A and B. Expression of CLCA1 subunits (38 KD and 90 KD) were up-regulated after 24 hour of confluent culture and reached a peak at
10 days of culture. C. ALPI as a marker of Caco-2 cell differentiation was up-regulated significantly after 4 days of confluent culture. D. Expression of
sucrase-isomaltase (SI), another cell differentiation marker, also was increased significantly after 4 days of confluent culture. E. Expression of b-catenin
was enhanced slightly over time in culture. The histograms in A to E show the relative intensity of CLCA1, ALPI, SI and b-catenin expressed as a ratio
with respect to the GAPDH control. All results were analyzed from three independent experiments.
doi:10.1371/journal.pone.0060861.g003
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b-catenin was down-regulated dramatically on the cell membrane
(Fig. 4). Our data implies that b-catenin is involved in the cascade
of events leading to differentiation and this is driven by CLCA1
activation in Caco-2 cells.
CLCA1 as a Target of Butyrate in Pro-differentiation and
Anti-proliferation
Butyrate is one of the most abundant short chain fatty acids
(SCFAs) and plays a key role in colonic epithelium homeostasis. It
is oxidized to acetyl CoA in mitochondria and represents the main
fuel for normal enterocytes [47,48], as well as for colon cancer cells
[49]. In human colon cancer cells, butyrate inhibits cell growth
[49,50,51] and promotes cell differentiation [52]. In addition,
butyrate-induced differentiation of PC12 cells to chromaffin cells
involves tight cell adhesion and the induction of extracellular cell
adhesion proteins [53]. Anticarcinogenic effects of butyrate have
been observed using carcinoma cell lines in vitro. In these models,
butyrate leads to inhibition of proliferation, induction of apoptosis,
or differentiation of tumor cells [54,55,56,57]. Furthermore, many
mechanisms of butyrate’s anticarcinogenic effects have been
reported, for example it is a histone deacetylase inhibitor
[58,59,60,61], increases p21 (WAF1) gene expression and induces
G1 cell cycle arrest [62]. Butyrate also down-regulates the key
apoptotic and angiogenesis regulator neuropilin-1 (NRP-1) to
inhibit tumor cell migration and survival in colon cancer [63]. In
addition, butryrate dysregulates Bcl2 family proteins [64,65],
induces GPR109A expression and activation of the receptor to
cause tumor cell–specific apoptosis [66], and modulates canonical
Wnt signaling [67]. Butyrate also increases the differentiation of
human LIM2537 colon cancer cells, decreases GSK-3b activity
and increases levels of both membrane-bound and Apc/axin/
GSK-3b complex-associated pools of b-catenin [39]. Butyrate is
recognized for its potential to act on secondary chemoprevention
[68]. Our results indicate that CLCA1 as a target of butyrate,
effectively regulate pro-differentiation and anti-proliferation in
Caco-2 cells (Fig. 2 and 5).
In summary, we reveal a novel mechanism that CLCA1
regulates the Wnt/b-catenin driven spontaneous and butyrate-
induced differentiation of enterocytes. This indicates that CLCA1
may control PDT of enterocyte and therefore act as a tumour
suppressor in colorectal tumorigenesis. Loss of CLCA1 expression
inhibits enterocyte differentiation and may lead to colonic cancer
Figure 4. CLCA1 is required for spontaneous differentiation in Caco-2 cells. A. Caco-2 cells were transfected transiently with 0, 50, 100, 150
and 200 nM siRNAclca1 and blotted for CLCA1. siRNAclca1 at 100 nM or above effectively inhibited CLCA1 and downregulated expression of ALPI and
b-catenin. B. Immunofluorescent staining showed the expression of b-catenin in confluent cultures of Caco-2 cells. b-catenin was located mainly in
the nucleus of the cells at early stages of culture (2 days). After 10 days culture, b-catenin had translocated to the cell membrane. Knockdown of
CLCA1 reduced distribution of b-catenin on the membrane. C. Caco-2 cells were treated with either siRNA negative control or siRNAclca1 and then
were cultured for 72 hours. Cell lysates were collected for detection of ALP activity using the Alkaline Phosphatase Detection Kit or for ALP expression
by western blot. The result shows that both ALP activity and expression were reduced significantly in CLCA1 knockdown cells. The histograms in A
showed the relative intensity of CLCA1 38 KD, 90 KD, ALPI and b-catenin expressed as a ratio with respect to the GAPDH control. All results were from
three independent experiments. **p,0.01.
doi:10.1371/journal.pone.0060861.g004
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development. Thus, better understanding of the CLCA1 pheno-
type in colonic epithelium and the mechanisms underlying loss of
expression in carcinomas may provide a means of therapeutic




The colon and rectal tissues were obtained from surgery of
patients in the Department of General Surgery, the 309th Hospital
of PLA, Beijing, China. Ethical approval for the study was granted
by the 309th Hospital of PLA Ethics Committee. Informed written
consent was obtained from all participants involved in the study.
Cell Culture
Caco-2 cells (ATCC, HTB-37) were cultured in Dulbecco’s
Modified Eagle Medium (DMEM) (Invitrogen, UK), supplement-
ed with 10% fetal bovine serum (FBS), 2 mM L-glutamine, non-
essential amino acids, 50 U/ml penicillin and 50 mg/ml strepto-
mycin at 37uC in a 5% CO2 incubator. Sodium butyrate was
purchased from Sigma-Aldrich, UK.
Knockdown of CLCA1 with siRNA
Knockdown of CLCA1 was performed using BLOCK-iTTM
RNAi Express search engine (Invitrogen, UK). Stealth RNAiTM
siRNA duplex with sense-strand sequences 59- CAAUGCUACC-
CUGCCUCCAAUUACA-39 was submitted in a BLAST search
of human EST libraries to ensure that other human genes were
not targeted. In brief, the cells were cultured in DMEM containing
10% FBS without antibiotics one day before transfection. Caco-2
cells then were transfected with CLCA1 specific siRNAs using
lipofectamine 2000 diluted in Opti-MEM I medium according to
manufacturer’s protocol (Invitrogen, UK) with a final siRNA
concentration from 50–200 nM for optimization of siRNA
transfection. Non-targeting negative control siRNA was used for
non-sequence-specific effects of these molecules. For 10 day
monolayer cultures, 56104 cells were plated into collagen I pre-
coating coverslips or 12-well plates. 100 nM of siRNA duplex was
transfected on the 2nd and 6th day of culture. After 10 days in
Figure 5. The effect of CLCA1 on proliferation of enterocytes. A. Caco-2 cells either treated by siRNA negative control, or with CLCA1 siRNA
alone, or with added NaBT were seeded in the 25% Matrigel and kept in 5% CO2 and 37uC for 5 days. The diameter of cysts was measured and
analyzed using Metamoph software. The mean colony size in Caco-2 CLCA1 knockdown cells increased significantly compared with control cells.
NaBT inhibited significantly the colony size, but knockdown of CLCA1 compromised NaBT-induced reduction of the colony size. Magnification of
objective is 106. 50 cysts were measured in each group in one experiment. B. Caco-2 cells were treated with negative control or CLCA1 siRNA and
cultured for the days indicated. Cell proliferation was detected with EdU incorporation assay. EdU was visualized using Alexa Fluor 594 (Red) and DNA
for DAPI (blue). The histogram presents the EdU positive % of cells in different groups and shows that knockdown of CLCA1 significantly increased
the cell proliferation. P values are shown on the histogram. N= 100 in each group in one experiment. Scale bar = 100 mm in A, 50 mm in B. The results
are shown as a mean6s.e.m from three independent experiments.
doi:10.1371/journal.pone.0060861.g005
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culture, cells on cover slips were fixed and cells in 12-well plate
were lysed for western blot analysis.
Quantitative PCR
Caco-2 cells were cultured in DMEM with/without 2 mM
NaBT treatment for 24 hours at 37uC with 5% CO2. Total RNA
was isolated using TRIzolH Reagent (Invitrogen, UK). cDNA was
synthesized with SuperScriptTM III Cells Direct cDNA Synthesis
System (Invitrogen, UK). Expression level of CLCA1, CLCA2,
CLCA3 and CLCA4 mRNA were determined using quantitative
real time polymerase chain reaction (qPCR). PCR primers were
designed using Primer3 online [34]. Human CLCA1, CLCA2,
CLCA3 and CLCA4 mRNA sequences were downloaded from
the National Center for Biotechnology Information (NCBI)
GenBank. Regions that matched the consensus sequence for
CLCA1, CLCA2, CLCA3 and CLCA4 were chosen for PCR
primers (Table 1). Primers were chosen to be 20 bp in length, with
a GC content of 55% and no long repeats of a single base. 1:5
diluted cDNA was used to run qPCR (SYBR green, Roche,
Switzerland) on LightCyclerH 480 System. All quantitative RT-
PCR assays were carried out in duplicates and repeated with
templates from 3 independent experiments, and analysed using
Lightcycler software (Roche, Switzerland).
Immunofluorescent Staining
The colon and rectal tissues were fixed with 4% paraformal-
dehyde in PBS for 2 hours. After paraffin embedding the tissue
was cut into 10 mm thick sections and mounted on charged glass
slides. Slides were de-paraffinized and subjected to citrate-based
antigen retrieval. Tissue sections were blocked with PBS contain-
ing 10% goat serum, 2% bovine serum albumin (BSA) plus 0.3%
Triton X-100 for one hour at room temperature to reduce non-
specific antigen binding. Rabbit anti-CLCA1 (1:100, Santa-Cruz,
USA) was applied overnight at 4uC in a moist chamber. After
washing with PBS, the tissue sections were incubated with Alexa
FluorH 555 highly cross-adsorbed secondary antibodies (Invitro-
gen, UK) and phalloidin-FITC (Sigma–Aldrich, UK) for 1 hour at
room temperature. For monolayer staining, cells were fixed in 4%
paraformaldehyde for 20 minutes, permeabilized for 5 minutes,
blocked for 30 minutes and followed by 2 hours incubation with b-
catenin (1:100, Cell Signaling, USA) antibodies. After washing
with PBS, cells were incubated with Alexa FluorH 488 highly cross-
adsorbed secondary antibodies (Invitrogen) for 1 hour. Both
colonic tissue and Caco-2 monolayers were mounted in Vector
mounting medium with DAPI (Vector Labs, UK) and sealed
under coverglass with clear nail polish. Images were obtained with
the Zeiss Axio Observer Z1 inverted fluorescence microscope for
tissue and with a confocal 700 LSM (Carl Zeiss, Germany) for
monolayers.
Western Blotting
56105 Caco-2 Cells were cultured on collagen I pre-coated 6-
well plates with different treatments for the indicated time. Cells
were rinsed with cold PBS and lysed with cell lysis buffer (Cell
signaling, USA) and a protease inhibitor cocktail (Roche,
Switzerland). Concentration of proteins was assessed with
Bradford assay (Pierce, USA). Equal amounts of protein lysates
were resolved by 4–12% SDS-PAGE, followed by electroblot
analysis onto nitrocellulose membranes. The membranes were
stained with Ponceau S for detection of transfer efficiency, then
were blocked with 5% milk TBS with 0.1% (w/v) Tween 20 for 1
hour. Primary antibodies used for WB included anti-CLCA1
(1:1000), anti-sucrase-isomaltase (1:400) (Santa Cruz, USA), anti-
ALPI (1:2000 NOVUS, USA), anti-b-catenin (1:3000, cell
signaling, USA) and anti-GAPDH (1:50,000 Santa Cruz, USA).
Membranes were incubated with the relevant primary antibodies
overnight at 4uC. The secondary antibody with horseradish
peroxidase (1:5000, Sigma-Aldrich, UK) was used, and the
immunoblots were detected by Luminata Forte Western HRP
substrate (Millipore).
Microarray Data Mining and Analysis
The microarray data sources were from the Gene Expression
Omnibus (GEO) [69]. Data sets were not subjected to any
additional normalization, as all had been normalized when we
obtained them [70]. Tumor specimens and adjacent grossly
normal-appearing tissue at least 8 cm away were routinely
collected and archived from patients undergoing colorectal
resection at the Singapore General Hospital (n = 12 from tumour
specimens, n = 10 from normal tissue). All patients, except one,
had early stage (Dukes A/B) tumors at the time of the operation.
Affymetrix Human Genome U133 Plus 2.0 Array (Affymetrix,
CA) was used for Genome-wide expression analysis [70]. We
filtered the GDS2609 data set for the expression of chloride
channel family members using the software on GEO. The identity
of genes across microarray data sets was established using public
annotations, primarily based on Unigene [71].
Differentiation and Proliferation Assays
Cellular differentiation of Caco-2 cells was measured after
72 hrs culture with either 100 nM negative control or CLCA1
siRNA treatment. Alkaline phosphatase activity was determined
using the Alkaline Phosphatase Detection Kit (BioVision) accord-
ing to manufacturer’s specifications. Fluorescence intensity at Ex/
Table 1. PCR primers for detection of members of CLCA.
Gene name Orientation Start Length Tm GC% Sequence (59-.39) Product Size
CLCA1 FORWARD 433 20 59.99 50 GCTGATGTTCTGGTTGCTGA 199
REVERSE 631 20 59.81 50 CGTCAAATACTCCCCATCGT
CLCA2 FORWARD 1239 20 59.83 60 GATCAGAGCCCAGCTACACC 197
REVERSE 1435 20 59.8 55 GCTTATCATCTCCGCTGGTC
CLCA3 FORWARD 1849 20 59.99 60 GCCCTACCACACTCCCAGTA 182
REVERSE 2030 20 60.07 50 ATTGTCCCAGAGCTCCAATG
CLCA4 FORWARD 1731 20 59.96 50 GGCACTTGGGCATACAATCT 200
REVERSE 1930 20 60.11 50 ACATTGGCTCCAAGAACAGG
doi:10.1371/journal.pone.0060861.t001
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Em 360/440 nm was recorded using a fluorescence microtiter
plate reader (Perkin-Elmer). All experiments were repeated at least
3 times and all measurements were performed in triplicate.
Cell proliferation was assessed by EdU (5-ethynyl-29-deoxyur-
idine) incorporation into DNA with a Click-iTH EdU kit
(Invitrogen). In brief, Caco-2 cells were cultured for the indicated
time and then were incubated with 10 mM of EdU for 2–4 h. The
cells were fixed with 4% paraformaldehyde in PBS and then were
detected for EdU staining following the manufactures instructions.
3D Culture Assay
The establishment of tumour cell 3D cultures was performed as
previously described [72]. Briefly, Caco-2 cells were seeded on top
of the solidified Matrigel (BD) layer in each well of an 8-well
chamber slide and incubated for 5 days to allow for multicellular
colonies to form. Phase contrast images were taken under light
microscopy. Images were analyzed using Metamorph software 7.0.
Colony formation as well as colony size reflects the number of cell
and tumour cell proliferation status.
Statistics
A minimum of three replicates was analyzed for each
experiment presented. Data are presented as the mean 6 s.e.m.
Student’s t test was used to assess the statistical significance.
Differences were considered as significant with a P value ,0.05.
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